Aprea Therapeutics Statistics Share Statistics Aprea Therapeutics has 5.53M
shares outstanding. The number of shares has increased by 1.83%
in one year.
Shares Outstanding 5.53M Shares Change (YoY) 1.83% Shares Change (QoQ) 0.72% Owned by Institutions (%) 32.53% Shares Floating 4.82M Failed to Deliver (FTD) Shares 14 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 63.19K, so 1.14% of the outstanding
shares have been sold short.
Short Interest 63.19K Short % of Shares Out 1.14% Short % of Float 1.29% Short Ratio (days to cover) 1.53
Valuation Ratios The PE ratio is -1.4 and the forward
PE ratio is -1.16.
Aprea Therapeutics's PEG ratio is
0.03.
PE Ratio -1.4 Forward PE -1.16 PS Ratio 12.06 Forward PS 10.5 PB Ratio 0.94 P/FCF Ratio -1.34 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aprea Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.01,
with a Debt / Equity ratio of 0.
Current Ratio 7.01 Quick Ratio 7.01 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $187.82K Profits Per Employee $-1.62M Employee Count 8 Asset Turnover 0.06 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -46.58% in the
last 52 weeks. The beta is 1.58, so Aprea Therapeutics's
price volatility has been higher than the market average.
Beta 1.58 52-Week Price Change -46.58% 50-Day Moving Average 1.77 200-Day Moving Average 2.58 Relative Strength Index (RSI) 47.27 Average Volume (20 Days) 52,520
Income Statement In the last 12 months, Aprea Therapeutics had revenue of 1.5M
and earned -12.96M
in profits. Earnings per share was -2.35.
Revenue 1.5M Gross Profit 1.48M Operating Income -14.32M Net Income -12.96M EBITDA -12.94M EBIT -12.96M Earnings Per Share (EPS) -2.35
Full Income Statement Balance Sheet The company has 22.85M in cash and 0 in
debt, giving a net cash position of 22.85M.
Cash & Cash Equivalents 22.85M Total Debt n/a Net Cash n/a Retained Earnings -321.04M Total Assets 20.22M Working Capital 16.47M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -13.56M
and capital expenditures -15.48K, giving a free cash flow of -13.57M.
Operating Cash Flow -13.56M Capital Expenditures -15.48K Free Cash Flow -13.57M FCF Per Share -2.46
Full Cash Flow Statement Margins Gross margin is 98.51%, with operating and profit margins of -953% and -862.43%.
Gross Margin 98.51% Operating Margin -953% Pretax Margin -862.43% Profit Margin -862.43% EBITDA Margin -860.94% EBIT Margin -953% FCF Margin -903.26%
Dividends & Yields APRE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for APRE is $15.5,
which is 801.2% higher than the current price. The consensus rating is "Buy".
Price Target $15.5 Price Target Difference 801.2% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 13, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Feb 13, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -22.77 Piotroski F-Score 1
